Background Clinical outcomes for transcatheter and operative closures of atrial septal defects (ASDs) are similar. Economic cost for each method has not been well described. Methods A single-center retrospective cohort study of children and adults<30 years of age undergoing closure for single secundum ASD from January 1, 2007, to April 1, 2012, was performed to measure differences in inflation-adjusted cost of operative and transcatheter closures of ASD. A propensity score weight-adjusted multivariate regression model was used in an intention-to-treat analysis. Costs for reintervention and crossover admissions were included in primary analysis. Results A total of 244 subjects were included in the study (64% transcatheter and 36% operative), of which 2% (n = 5) were ≥18 years. Crossover rate from transcatheter to operative group was 3%. Risk of reintervention (P =.66) and 30-day mortality (P =.37) were not significantly different. In a multivariate model, adjusted cost of operative closure was 2012 US $60,992 versus 2012 US $55,841 for transcatheter closure (P
CITATION STYLE
O’Byrne, M. L., Gillespie, M. J., Shinohara, R. T., Dori, Y., Rome, J. J., & Glatz, A. C. (2015). Cost comparison of transcatheter and operative closures of ostium secundum atrial septal defects. American Heart Journal, 169(5), 727-735.e2. https://doi.org/10.1016/j.ahj.2015.02.010
Mendeley helps you to discover research relevant for your work.